Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

5,323 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity ▾	Revenue growth	Diluted EPS
RTCJF	Baijiayun Group Ltd Services · Year ended 2025-06-30 · USD	$42.54M	-$18.67M	-43.9%	-144.5%	-28.9%	-$15.58
PRLD	Prelude Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$12.14M	-$99.50M	-819.6%	-145.0%	73.4%	-$1.29
KOD	Kodiak Sciences Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$229.97M	n/a	-146.1%	n/a	-$4.32
AEMD	Aethlon Medical Inc Manufacturing · Year ended 2026-03-31 · USD	n/a	-$7.15M	n/a	-146.4%	n/a	-$10.61
LCTX	Lineage Cell Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$14.56M	-$63.53M	-436.5%	-146.6%	53.2%	-$0.28
CDZI	Cadiz Inc Transportation & Utilities · Year ended 2025-12-31 · USD	$16.31M	-$34.15M	-209.3%	-146.8%	69.8%	n/a
EHSI	Elite Health Systems Inc. Services · Year ended 2025-12-31 · USD	$1.02M	-$7.80M	-762.1%	-146.9%	n/a	n/a
TE	T1 Energy Inc. Manufacturing · Year ended 2025-12-31 · USD	$755.29M	-$367.83M	-48.7%	-146.9%	n/m	-$2.19
CRVO	CervoMed Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.01M	-$26.97M	-673.1%	-148.0%	-58.9%	n/a
FRGT	Freight Technologies, Inc. Transportation & Utilities · Year ended 2025-12-31 · USD	$13.06M	-$7.90M	-60.5%	-148.3%	-4.9%	-$13.95
WKHS	Workhorse Group Inc. Manufacturing · Year ended 2025-12-31 · USD	$21.21M	-$64.09M	-302.1%	-148.9%	201.1%	-$6.76
PVLA	Palvella Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$41.72M	n/a	-149.1%	n/a	-$3.71
PYXS	Pyxis Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.86M	-$79.62M	-574.5%	-149.1%	-14.2%	-$1.28
FLNT	Fluent, Inc. Services · Year ended 2025-12-31 · USD	$208.76M	-$27.17M	-13.0%	-149.2%	-18.0%	-$1.05
LITE	Lumentum Holdings Inc. Manufacturing · Year ended 2026-06-27 · USD	$3.01B	-$6.94B	-230.1%	-149.3%	83.2%	-$92.96
APVO	Aptevo Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$25.97M	n/a	-149.4%	n/a	-$87.27
CABA	Cabaletta Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$167.86M	n/a	-149.8%	n/a	-$2.10
SPRY	ARS Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$84.28M	-$171.30M	-203.3%	-149.9%	-5.5%	-$1.74
MIST	Milestone Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$63.06M	n/a	-151.0%	n/a	-$0.75
ADIL	Adial Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$7.98M	n/a	-151.2%	n/a	-$11.93
ACXP	Acurx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$7.97M	n/a	-151.2%	n/a	-$5.32
SANA	Sana Biotechnology, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$244.17M	n/a	-151.8%	n/a	-$0.96
BCTX	BriaCell Therapeutics Corp. Manufacturing · Year ended 2025-07-31 · USD	n/a	-$26.31M	n/a	-151.8%	n/a	-$62.19
MWYN	Marwynn Holdings, Inc. Wholesale Trade · Year ended 2026-04-30 · USD	$4.24M	-$3.92M	-92.4%	-151.8%	427.5%	-$0.21
AIRE	reAlpha Tech Corp. Finance & Real Estate · Year ended 2025-12-31 · USD	$4.52M	-$17.59M	-389.4%	-153.1%	376.4%	-$0.23

Rows per page: 2550 100